Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9446602 | 0.88 | SLC6A4 (0.36) | SLC6A4NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL22184478 | 0.86 | — | — | |
| SCHEMBL19555536 | 0.83 | SLC6A4 (0.32) | SLC6A4 | |
| SCHEMBL4940686 | 0.81 | SLC6A4 (0.38) | SLC6A4ALDH1A1TSHR | |
| SCHEMBL468003 | 0.81 | — | — | |
| SCHEMBL1551333 | 0.80 | MAPT (0.35) | SLC6A4NPC1RAB9ASMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL9255979 | 0.79 | — | — | |
| Bromide SCHEMBL28594415 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL437245 | 0.78 | MAPT (0.34) | NPC1RAB9ASMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL175677 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064357-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LITHIASIS DISORDERS | TRICIDA, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| EP-3740201-A1 | METHOD OF TREATING ACID-BASE DISORDERS | Tricida Inc. (US) | 2020-11-25 | — | — | EP | disclosed |
| EP-3703707-A1 | METHOD OF TREATING ACID-BASE DISORDERS | Tricida, Inc. (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3703706-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | Tricida Inc. (US) | 2020-09-09 | — | — | EP | disclosed |
| EP-3452028-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | Tricida Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| EP-3452057-A1 | COMPOSITIONS FOR TREATING ACID-BASE DISORDERS | Tricida Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| CN-109414453-A | composition for treating acid-base imbalance | 特里赛达公司 | 2019-03-01 | — | — | CN | disclosed |
| WO-2017193024-A9 | HCL-BINDING COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | TRICIDA, INC. (US) | 2018-11-22 | — | — | WO | disclosed |
| WO-2017193024-A1 | HCL-BINDING COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | TRICIDA, INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| WO-2017193064-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | TRICIDA, INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| WO-2017193050-A1 | COMPOSITIONS FOR TREATING ACID-BASE DISORDERS | TRICIDA, INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| EP-3229816-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | Tricida Inc. (US) | 2017-10-18 | — | — | EP | disclosed |
| WO-2016094685-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA, INC. (US) | 2016-06-16 | — | — | WO | disclosed |
| EP-3003327-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | Tricida Inc. (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014197725-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA, INC. (US) | 2014-12-11 | — | — | WO | disclosed |
| EP-0865450-B1 | PROCESS FOR THE REMOVAL OF RESIDUAL SOLVENTS AND RESIDUAL MONOMERS FROM POWDERED POLYMERISATES | BASF AG (DE) | 1999-08-18 | — | — | EP | disclosed |